Skip to main content
. 2023 Jan 3;20(1):e1003988. doi: 10.1371/journal.pmed.1003988

Fig 5. A DAG showing the putative association between PCSK9 inhibition, lipoprotein A, and prostate cancer.

Fig 5

DAG, directed acyclic graph.